526445
INDRANIB
Start SIP
Invest Now
Start SIP in INDRANIB
Performance
- Low
- ₹9
- High
- ₹9
- 52 Week Low
- ₹8
- 52 Week High
- ₹26
- Open Price₹9
- Previous Close₹9
- Volume54,265
- 50 DMA₹10.80
- 100 DMA₹12.17
- 200 DMA₹15.60
Investment Returns
- Over 1 Month -13.88%
- Over 3 Month -42.01%
- Over 6 Month -35.9%
- Over 1 Year -66.4%
Smart Investing Starts Here Start SIP with Indrayani Biotech for Steady Growth!
Indrayani Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -5.2
- PEG Ratio
- 0
- Market Cap Cr
- 40
- P/B Ratio
- 0.5
- Average True Range
- 0.79
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.76
- RSI
- 36.49
- MFI
- 32.43
Indrayani Biotech Financials
Indrayani Biotech Technicals
EMA & SMA
Current Price
₹8.75
-0.09
(-1.02%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹9.44
- 50 Day
- ₹10.80
- 100 Day
- ₹12.17
- 200 Day
- ₹15.60
Resistance and Support
8.78
- R3 9.50
- R2 9.26
- R1 9.02
- S1 8.54
- S2 8.30
- S3 8.06
Indrayani Biotech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-12-11 | Quarterly Results | |
| 2025-08-30 | Others | Inter-alia, to consider 1. Notice of the 33rd AGM of the Company. 2. Appointment of Mr. Swaminathan & Mr. Singarababu Indirakumar as Whole-Time Director. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-06-12 | Audited Results | (Revised) |
| 2025-04-03 | Rights issue of Equity Shares |
Indrayani Biotech F&O
About Indrayani Biotech
- NSE Symbol
- INDRANIB
- BSE Symbol
- 526445
- Managing Director
- Mr. Kasiraman Sayee Sundar
- ISIN
- INE007C01021
Similar Stocks to Indrayani Biotech
Indrayani Biotech FAQs
Indrayani Biotech share price is ₹8 As on 12 February, 2026 | 05:37
The Market Cap of Indrayani Biotech is ₹39.8 Cr As on 12 February, 2026 | 05:37
The P/E ratio of Indrayani Biotech is -5.2 As on 12 February, 2026 | 05:37
The PB ratio of Indrayani Biotech is 0.5 As on 12 February, 2026 | 05:37
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.